Eckstein A - Search Results

1

Gulbins A, Görtz GE, Gulbins E, Eckstein A. Gulbins A, et al. Among authors: eckstein a. Front Endocrinol (Lausanne). 2023 Apr 4;14:1170884. doi: 10.3389/fendo.2023.1170884. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37082124 Free PMC article. Review.

2

Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.

Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG. Eckstein AK, et al. Clin Endocrinol (Oxf). 2004 Nov;61(5):612-8. doi: 10.1111/j.1365-2265.2004.02143.x. Clin Endocrinol (Oxf). 2004. PMID: 15521965

3

Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.

Eckstein AK, Lax H, Lösch C, Glowacka D, Plicht M, Mann K, Esser J, Morgenthaler NG. Eckstein AK, et al. Clin Endocrinol (Oxf). 2007 Oct;67(4):607-12. doi: 10.1111/j.1365-2265.2007.02933.x. Clin Endocrinol (Oxf). 2007. PMID: 17880407

4

[Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].

Eckstein A, Mann K, Kahaly GJ, Grussendorf M, Reiners C, Feldkamp J, Quadbeck B, Bockisch A, Schott M. Eckstein A, et al. Med Klin (Munich). 2009 May 15;104(5):343-8. doi: 10.1007/s00063-009-1072-0. Epub 2009 May 16. Med Klin (Munich). 2009. PMID: 19444414 Review. German.

5

Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.

Eckstein A, Esser J, Mann K, Schott M. Eckstein A, et al. Pediatr Endocrinol Rev. 2010 Mar;7 Suppl 2:198-203. Pediatr Endocrinol Rev. 2010. PMID: 20467363 Review.

6

A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbit.

Meyer zu Hörste M, Ströher E, Berchner-Pfannschmidt U, Schmitz-Spanke S, Pink M, Göthert JR, Fischer JW, Gulbins E, Eckstein AK. Meyer zu Hörste M, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):E1727-36. doi: 10.1210/jc.2011-1156. Epub 2011 Sep 14. J Clin Endocrinol Metab. 2011. PMID: 21917865

7

Examination of orbital tissues in murine models of Graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues.

Johnson KT, Wiesweg B, Schott M, Ehlers M, Müller M, Minich WB, Nagayama Y, Gulbins E, Eckstein AK, Berchner-Pfannschmidt U. Johnson KT, et al. Among authors: eckstein ak. Horm Metab Res. 2013 Jun;45(6):401-7. doi: 10.1055/s-0032-1333224. Epub 2013 Feb 5. Horm Metab Res. 2013. PMID: 23386414

8

Current insights into animal models of Graves' disease and orbitopathy.

Wiesweg B, Johnson KT, Eckstein AK, Berchner-Pfannschmidt U. Wiesweg B, et al. Among authors: eckstein ak. Horm Metab Res. 2013 Aug;45(8):549-55. doi: 10.1055/s-0033-1343451. Epub 2013 Apr 23. Horm Metab Res. 2013. PMID: 23613015 Review.

9

Modeling Graves' Orbitopathy in Experimental Graves' Disease.

Banga JP, Moshkelgosha S, Berchner-Pfannschmidt U, Eckstein A. Banga JP, et al. Among authors: eckstein a. Horm Metab Res. 2015 Sep;47(10):797-803. doi: 10.1055/s-0035-1555956. Epub 2015 Aug 19. Horm Metab Res. 2015. PMID: 26287396 Review.

10

Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.

Brandau S, Bruderek K, Hestermann K, Görtz GE, Horstmann M, Mattheis S, Lang S, Eckstein A, Berchner-Pfannschmidt U. Brandau S, et al. Among authors: eckstein a. Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6549-57. doi: 10.1167/iovs.15-16610. Invest Ophthalmol Vis Sci. 2015. PMID: 26457540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page